Clinical Study

Intention

Communication

Sensation

Creation

Transformation

Intention

Communication

Sensation

Creation

Transformation

Intention

Communication

Sensation

Creation

Transformation

The future should be defined by possibility, not limitation. Paradromics is building a scalable, high-performance BCI platform to restore capabilities lost to disease or injury today and expand how people communicate, control, create, and experience tomorrow.

Our platform combines fully implantable neural hardware, data capture, and full-stack neural decoding in an architecture designed to scale in both electrode count and data rate. As the platform advances, it is designed to support an expanding range of applications including robotics, sensory feedback, neurotherapeutics, and direct AI integration, while creating a foundation for clinical, research, technology, and application partners to restore what is lost and expand what is possible.

The Paradromics Difference

Higher data rates expand what BCI can do

Our BCI platform has demonstrated information transfer rates above 200 bits per second, 20x faster than any other BCI technology, and our core architecture is designed to scale electrode count and data rate across future generations. As BCI applications become more capable and complex, greater neural bandwidth will create the foundation for richer communication, control, AI integration, and entirely new applications.

Designed for life

A permanent neural interface should be built for the life of the person who depends on it. Connexus® BCI is engineered with durable, biocompatible materials and an architecture designed to support stable neural recording for a decade or more, reducing the potential need for repeat brain surgeries and giving patients greater confidence in the technology they rely on.

Built for clinical adoption

Connexus BCI is designed around established neurosurgical techniques, familiar clinical workflows, and medical-grade materials, helping reduce the specialized infrastructure required to bring BCI technology into clinical practice and supporting broader access as the platform expands. No proprietary robots. Just good surgeons.

The Next Frontier of Human Capability

Built to support the next generation of BCI applications

From restoring communication and control today to enabling new forms of interaction with technology tomorrow. By connecting high-performance modules with different regions of the brain, the platform can support increasingly advanced applications and, over time, multiple functions through a single neural interface.
TODAY

Restoring lost connections

  • Communication
  • Advanced computer control
TOMORROW

Enabling new frontiers

  • Precision control of prosthetics and humanoid robotics
  • Targeted neuromodulation
  • Sensory restoration and augmentation
  • Cognitive interfaces
Image

Our BCI platform will lead to life-changing therapies

and unprecedented capabilities for human-technology integration.

Our Products

Image

Connexus® BCI

Designed for real-time speech, plus digital device control.

Current FDA-Authorized Human Clinical Study

Connexus BCI is an investigational device limited by United States law to investigational.

Image

Tempo® BCI

Designed for ambulatory users and mobile BCI applications.

Pre-Clinical Trial Phase

Tempo BCI is in a pre-clinical-trial phase.